期刊文献+

普瑞巴林的药理作用及临床评价 被引量:39

Pharmacology and clinical evaluation of pregabalin
原文传递
导出
摘要 普瑞巴林为一新型神经递质γ-氨基丁酸结构类似物,口服易吸收,与其他抗癫痫药物相互作用小,且耐受性好。临床研究表明,普瑞巴林治疗癫痫及外周神经痛具有良好的临床疗效和安全性。本文对其作用机制、药动学、药物相互作用、临床应用和药物不良反应等作一综述。 Pregabalin is a new structural analogue of γ-aminobutyric acid as a neurotransmitter regulator.It can be absorbed quickly.Pregabalin has little interaction with other antiepileptic drugs and has good tolerability.Clinical trials showed that pregabalin as antiepileptic and antineuropathic pain agent was effective and safe.This paper reviews the mechanism,pharmacokinetics,drug interactions,clinical application and safety of pregabalin.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2010年第1期11-14,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 癫痫 药理作用 神经痛 普瑞巴林 epilepsy pharmacologic action neuralgia pregabalin
作者简介 陈宝泉(1964-),男,正高级工程师,硕士,硕士生导师,主要从事新药研究与药学教学工作。E-mail:chenbaoquan6@yahoo.com.cn
  • 相关文献

参考文献25

  • 1BRYANS JS, WUSTROW DJ. 3-substituted GABA analogs with central nervous system activity: a review[J]. Med Res Rev,1999, 19(2):149-177.
  • 2SINGH D, KENNEDY DH. The use of gabapentin for the treatment of postherpetic neuralgia[J]. Clin Ther, 2003, 25 (3): 852-889.
  • 3PELLOCK JM. Treatment of epilepsy in the new millennium[J]. Pharmacotherapy, 2000, 20(8 Pt 2):129S-138S.
  • 4OWEN RT. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety[J]. Drugs Today (Barc), 2007, 43 (9) : 601-610.
  • 5RANDINITIS EJ, POSVAR EL, ALVEY CW, et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function[J]. J Clin Pharmacol, 2003, 43(3): 277-283.
  • 6PENOVICH PE, DICKENS DL, DOESCHER JS, et al. Pregabalin dosing and serum levels[J]. Epilepsia, 2006, 47 Suppl 4: S196.
  • 7郭歆,刘晓磊,程航,曹亚杰,曹伟,龚倩,李筱旻,程泽能.普瑞巴林胶囊的人体药动学研究[J].中国药学杂志,2009,44(5):362-366. 被引量:8
  • 8BRODIE M J, WILSON EA, WESCHE DL, et al. Pregabalin drug interaction studies : lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy[J]. Epilepsia, 2005, 46 (9): 1407-1413.
  • 9BOCKBRADER H, MILLER R, FRAME B, et al. The concomitant use of pregabalin and oral contraceptives does not affect the efficacy of either agent[J]. Epilepsia, 2005, 46 Suppl 8: S170.
  • 10HURLEY RW, CHATTERJEA D, ROSE FENG M, et al. Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia[J]. Anesthesiology, 2002, 97 (5): 1263-1273.

二级参考文献12

  • 1LAURIA HORNER B A, POHLI R B. Pregabalin: a new anxiolytic [J]. Expert Opin Investig Drugs, 2003, 12(4): 663-672.
  • 2OWEN R T. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety [J]. Drugs Today, 2007, 43(9): 601-610.
  • 3SHNEKER B F, MCAULEY J W. Pregabalin: a new neuromodulator with broad therapeutic indications [J]. Ann Pharmacother, 2005, 39(12): 2029-2037.
  • 4GUAY D R. Pregabalin in neuropathic pain "pharmaceutically elegant" gabapentin[J]. Am J Geriatr Pharmaeother, 2005, 3(4): 274-287.
  • 5JOHANNESSEN S I, TOMSON T. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed [J]. Clin Pharmacokinet, 2006, 45(11): 1061-1075.
  • 6PERUCCA E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age [J]. Clin Pharmacokinet, 2006, 45(4): 351-363.
  • 7BIALER M. The pharmacokinetics and interactions of new antiepileptic drugs: an overview [J]. Ther Drug Monit, 2005, 27(6): 722-726.
  • 8RANDINITIS E J, POSVAR E L, ALVEY C W, et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function [J]. J Clin Pharmacol, 2003, 43(3): 277-283.
  • 9BERRY D, MILLINGTON C. Analysis ofpregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC [J]. Ther Drug Monit, 2005, 27(4): 451-456.
  • 10VERMEIJ T A, EDELBROEK P M J. Simultaneous high- performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection [J]. Chromatogr B Analyt Teehnol Biomed Life Sci, 2004, 810(2): 297-303.

共引文献7

同被引文献261

引证文献39

二级引证文献187

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部